Caspase-8 inhibition represses initial human monocyte activation in septic shock model

Oncotarget

Volumn 7, Issue 25, 2016, Pages 37456-37470

  Oliva Martin, Maria Jose ^a,b,c   Sanchez Abarca, Luis Ignacio ^b,c   Rodhe, Johanna ^a,c   Carrillo Jimenez, Alejandro ^a,c   Vlachos, Pinelopi ^a,c   Herrera, Antonio Jose ^a,c   Garcia Quintanilla, Albert ^a,c   Caballero Velazquez, Teresa ^b,c   Perez Simon, Jose Antonio ^b,c   Joseph, Bertrand ^a,c   Venero, Jose Luis ^a,c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Caspase 8; Inflammation; Monocyte; Necroptosis; Pathology Section; Sepsis

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; CASPASE INHIBITOR; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE STORM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; MICROGLIA; MONOCYTE; MOUSE; MOUSE MODEL; NECROPTOSIS; NONHUMAN; PROTEIN EXPRESSION; SEPTIC SHOCK; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CASPASE 8; CASPASE INHIBITORS; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; SHOCK, SEPTIC;

EID: 84978129558     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9648     Document Type: Article

References (54)

1. Ward PA and Bosmann M. A Historical Perspective on Sepsis. American Journal of Pathology. 2012; 181:2-7.
2. Uppu DSSM, Ghosh C and Haldar J. Surviving sepsis in the era of antibiotic resistance: Are there any alternative approaches to antibiotic therapy? Microbial Pathogenesis. 2015; 80:7-13.
3. Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, Garcia G, Rodriguez Diaz-Reganon I and Ruiz de Luna R. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Critical Care Medicine. 2007; 35:1284-1289.
4. Kang J, Kim S, Cho H and SM L. DAMPs activating innate immune responses in sepsis. Ageing Res Rev 2015; [Epub ahead of print].
5. Feldman N, Rotter-Maskowitz A and Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 2015; [Epub ahead of print].
6. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S and Remick DG. The Pathogenesis of Sepsis. Annual review of pathology. 2011; 6:19-48.
7. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M and Zieglerheitbrock HWL. THE NOVEL SUBSET OF CD14+/CD16+ BLOOD MONOCYTES IS EXPANDED IN SEPSIS PATIENTS. Blood. 1993; 82:3170-3176.
8. Serbina NV, Jia T, Hohl TM and Pamer EG. Monocyte-Mediated Defense Against Microbial Pathogens. Annu Rev Immunol. 2008; 26:421-452.
9. Lewis DH, Chan DL, Pinheiro D, Armitage-Chan E and Garden OA. The Immunopathology of Sepsis: Pathogen Recognition, Systemic Inflammation, the Compensatory Anti-Inflammatory Response, and Regulatory T Cells. Journal of Veterinary Internal Medicine. 2012; 26:457-482.
10. Bosmann M and Ward PA. The inflammatory response in sepsis. Trends in Immunology. 2013; 34:129-136.
11. Weber GF, Chousterman BG, He S, Fenn AM, Nairz M, Anzai A, Brenner T, Uhle F, Iwamoto Y, Robbins CS, Noiret L, Maier SL, Zoennchen T, Rahbari NN, Schoelch S, Ameln AK-v, et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science. 2015; 347:1260-1265.
12. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, Aspiotis R, Han Y, Nicholson DW and Karl IE. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nature Immunology. 2000; 1:496-501.
13. Sharawy N and Lehmann C. New directions for sepsis and septic shock research. Journal of Surgical Research. 2015; 194:520-527.
14. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Medicine. 2013; 39:165-228.
15. Matsuda A, Jacob A, Wu R, Aziz M, Yang W-L, Matsutani T, Suzuki H, Furukawa K, Uchida E and Wang P. Novel Therapeutic Targets for Sepsis: Regulation of Exaggerated Inflammatory Responses. Journal of Nippon Medical School. 2012; 79:4-18.
16. Antonopoulou A and Giamarellos-Bourboulis EJ. Immunomodulation in sepsis: state of the art and future perspective. Immunotherapy. 2010; 3:117-128.
17. Oberst A and Green DR. It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nature Reviews Molecular Cell Biology. 2011; 12:757-763.
18. Sordet O, Rebe C, Plenchette S, Zermati Y, Hermine O, Vainchenker W, Garrido C, Solary E and Dubrez-Daloz L. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood. 2002; 100:4446-4453.
19. Jacquel A, Benikhlef N, Paggetti J, Lalaoui N, Guery L, Dufour EK, Ciudad M, Racoeur C, Micheau O, Delva L, Droin N and Solary E. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. Blood. 2009; 114:3633-3641.
20. Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, Vandenabeele P, Droin N and Solary E. Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood. 2011; 118:4694-4704.
21. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL and Joseph B. Caspase signalling controls microglia activation and neurotoxicity. Nature. 2011; 472:319-U214.
22. Kavanagh E, Rodhe J, Burguillos MA, Venero JL and Joseph B. Regulation of caspase-3 processing by cIAP2 controls the switch between pro-inflammatory activation and cell death in microglia. Cell Death & Disease. 2014; 5.
23. Silke J, Rickard J and Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nature Immunology. 2015; 16:689-697.
24. Vandenabeele P, Galluzzi L, Vanden Berghe T and Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology. 2010; 11:700-714.
25. de Almagro MC and Vucic D. Necroptosis: Pathway diversity and characteristics. Seminars in Cell & Developmental Biology. 2015; 39:56-62.
26. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang J-G, Alvarez-Diaz S, Lewis R, Lalaoui N, Metcalf D, Webb AI, Young SN, Varghese LN, Tannahill GM, Hatchell EC, Majewski IJ, Okamoto T, et al. The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism. Immunity. 2013; 39:443-453.
27. Kaczmarek A, Vandenabeele P and Krysko DV. Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance. Immunity. 2013; 38:209-223.
28. Yang J, Zhang L, Yu C, Yang X-F and Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomarker research. 2014; 2:1-1.
29. Ye M, Iwasaki H, Laiosa CV, Stadtfeld M, Xie H, Heck S, Clausen B, Akashi K and Graf T. Hematopoietic stem cells expressing the myeloid lysozyme gene retain longterm, multilineage repopulation potential. Immunity. 2003; 19:689-699.
30. Kavanagh E, Angel Burguillos M, Carrillo-Jimenez A, Jose Oliva-Martin M, Santiago M, Rodhe J, Joseph B and Luis Venero J. Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model. Aging (Albany NY). 2015;7:673-89. doi: 10.18632/aging.100805.
31. Wieghofer P, Knobeloch KP and Prinz M. Genetic targeting of microglia. Glia. 2015; 63:1-22.
32. Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, Luedde T, Heikenwalder M, Jung S and Prinz M. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci. 2013; 16:1618-1626.
33. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES and Zeng H. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010; 13:133-140.
34. Immig K, Gericke M, Menzel F, Merz F, Krueger M, Schiefenhovel F, Losche A, Jager K, Hanisch UK, Biber K and Bechmann I. CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia. 2015; 63:611-625.
35. Oliva-Martin MJ, Ignacio Sanchez-Abarca L, Carrillo-Jimenez A, Perez-Simon JA and Venero JL. Evaluation of a method for murine monocyte isolation by bone marrow depletion. Analytical Biochemistry. 2015; 480:42-48.
36. Sakamaki K and Satou Y. Caspases: evolutionary aspects of their functions in vertebrates. Journal of Fish Biology. 2009; 74:727-753.
37. Karlmark KR, Tacke F and Dunay IR. Monocytes in health and disease-Minireview. European journal of microbiology & immunology. 2012; 2:97-102.
38. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T and Wallach D. Caspase-8 serves both apoptotic and nonapoptotic roles. Journal of Immunology. 2004; 173:2976-2984.
39. Rebe C, Cathelin S, Launay S, Filomenko R, Prevotat L, L'Ollivier C, Gyan E, Micheau O, Grant S, Dubart-Kupperschmitt A, Fontenay M and Solary E. Caspase-8 prevents sustained activation of NF-kappa B in monocytes undergoing macrophagic differentiation. Blood. 2007; 109:1442-1450.
40. Fuchs Y and Steller H. Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat Rev Mol Cell Biol. 2015; 16:329-344.
41. Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T, Declercq W, Libert C, Cauwels A and Vandenabeele P. RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome. Immunity. 2011; 35:908-918.
42. de Pablo R, Monserrat J, Prieto A and Alvarez-Mon M. Role of Circulating Lymphocytes in Patients with Sepsis. Biomed Research International. 2014.
43. Fricker M, Vilalta A, Tolkovsky AM and Brown GC. Caspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia. Journal of Biological Chemistry. 2013; 288:9145-9152.
44. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund A-C, Chapman DC, Durchschlag M, Joza N, Pierron G, van Endert P, Yuan J, Zitvogel L, Madeo F, Williams DB and Kroemer G. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. Embo Journal. 2009; 28:578-590.
45. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, Davis CG, Osborne DF and Karl IE. (2003). Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A, pp. 6724-6729.
46. Antonopoulos C, Russo H, El Sanadi C, Martin B, Li X, Kaiser W, Mocarski E and Dubyak G. Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling. J Biol Chem. 2015; [Epub ahead of print].
47. Kang T-B, Yang S-H, Toth B, Kovalenko A and Wallach D. Caspase-8 Blocks Kinase RIPK3-Mediated Activation of the NLRP3 Inflammasome. Immunity. 2013; 38:27-40.
48. Carta S, Tassi S, Pettinati I, Delfino L, Dinarello CA and Rubartelli A. (2011). The Rate of Interleukin-1 Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering. J Biol Chem. (9650 Rockville Pike, Bethesda, MD 20814, U.S.A., pp. 27069-27080.
49. Bossaller L, Chiang PI, Schmidt-Lauber C, Ganesan S, Kaiser WJ, Rathinam VAK, Mocarski ES, Subramanian D, Green DR, Silverman N, Fitzgerald KA, Marshak-Rothstein A and Latz E. FAS mediates non-canonical IL-1 and IL-18 maturation via caspase-8 in a Rip3-independent manner(). Journal of immunology (Baltimore, Md: 1950). 2012; 189:5508-5512.
50. Maelfait J, Vercammen E, Janssens S, Schotte P, Haegman M, Magez S and Beyaert R. (2008). Stimulation of Tolllike receptor 3 and 4 induces interleukin-1 maturation by caspase-8. J Exp Med, pp. 1967-1973.
51. Shenderov K, Riteau N, Yip R, Mayer-Barber KD, Oland S, Hieny S, Fitzgerald P, Oberst A, Dillon CP, Green DR, Cerundolo V and Sher A. ER stress licenses macrophages to produce mature IL-1 in response to TLR4 stimulation through a caspase-8-and TRIF-dependent pathway. Journal of immunology (Baltimore, Md: 1950). 2014; 192:2029-2033.
52. Gurung P, Anand PK, Malireddi RK, Vande Walle L, Van Opdenbosch N, Dillon CP, Weinlich R, Green DR, Lamkanfi M and Kanneganti TD. FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes. Journal of immunology (Baltimore, Md: 1950). 2014; 192:1835-1846.
53. Weber P, Wang P, Maddens S, Wang PSH, Wu R, Miksa M, Dong W, Mortimore M, Golec JMC and Charlton P. VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis. Critical Care. 2009; 13.
54. Ch'en IL, Tsau JS, Molkentin JD, Komatsu M and Hedrick SM. Mechanisms of necroptosis in T cells. Journal of Experimental Medicine. 2011; 208:633-641.